The Prague Post - Who should get paid for nature's sequenced genes?

EUR -
AED 4.304872
AFN 79.965899
ALL 97.125019
AMD 446.577098
ANG 2.097965
AOA 1074.898555
ARS 1598.611316
AUD 1.789603
AWG 2.112872
AZN 1.997376
BAM 1.9557
BBD 2.354679
BDT 142.282703
BGN 1.957991
BHD 0.440777
BIF 3488.121114
BMD 1.17219
BND 1.504223
BOB 8.078586
BRL 6.347648
BSD 1.16914
BTN 103.189708
BWP 15.718194
BYN 3.950497
BYR 22974.921746
BZD 2.351279
CAD 1.621549
CDF 3370.046344
CHF 0.935548
CLF 0.028827
CLP 1136.571712
CNY 8.361055
CNH 8.352961
COP 4662.360894
CRC 592.369621
CUC 1.17219
CUP 31.063032
CVE 110.259345
CZK 24.39269
DJF 208.189323
DKK 7.468144
DOP 73.936208
DZD 152.0892
EGP 56.894082
ERN 17.582848
ETB 167.236523
FJD 2.640714
FKP 0.865674
GBP 0.867775
GEL 3.169438
GGP 0.865674
GHS 14.146275
GIP 0.865674
GMD 83.816091
GNF 10133.480311
GTQ 8.96654
GYD 244.597456
HKD 9.138514
HNL 30.630429
HRK 7.536951
HTG 152.802164
HUF 393.047445
IDR 19198.94647
ILS 3.922435
IMP 0.865674
INR 103.371328
IQD 1531.621452
IRR 49319.889825
ISK 143.183447
JEP 0.865674
JMD 187.070406
JOD 0.831129
JPY 172.786696
KES 151.282242
KGS 102.508456
KHR 4687.759591
KMF 492.910294
KPW 1055.010338
KRW 1625.245717
KWD 0.358128
KYD 0.97425
KZT 628.297778
LAK 25364.699188
LBP 104693.130882
LKR 353.011896
LRD 234.407979
LSL 20.66744
LTL 3.461172
LVL 0.709046
LYD 6.346675
MAD 10.625055
MDL 19.622994
MGA 5199.733335
MKD 61.536844
MMK 2461.015377
MNT 4215.456348
MOP 9.396018
MRU 46.869596
MUR 54.003232
MVR 18.063889
MWK 2027.196037
MXN 21.937773
MYR 4.9511
MZN 74.907305
NAD 20.66744
NGN 1793.450927
NIO 43.027793
NOK 11.779692
NPR 165.103533
NZD 1.989123
OMR 0.450307
PAB 1.16914
PEN 4.118089
PGK 4.87975
PHP 66.467508
PKR 331.750386
PLN 4.251254
PYG 8426.567849
QAR 4.273081
RON 5.078166
RSD 117.173991
RUB 95.15882
RWF 1693.413154
SAR 4.395986
SBD 9.639882
SCR 17.321412
SDG 703.904335
SEK 11.01308
SGD 1.506503
SHP 0.921157
SLE 27.25385
SLL 24580.233414
SOS 668.165734
SRD 45.571817
STD 24261.963978
STN 24.498744
SVC 10.229475
SYP 15240.810434
SZL 20.66094
THB 37.604284
TJS 11.048033
TMT 4.114386
TND 3.419025
TOP 2.74539
TRY 48.297158
TTD 7.934593
TWD 35.778991
TZS 2928.649806
UAH 48.191829
UGX 4112.789078
USD 1.17219
UYU 46.837598
UZS 14540.254313
VES 178.912011
VND 30945.812964
VUV 140.990019
WST 3.253432
XAF 655.923361
XAG 0.028581
XAU 0.000327
XCD 3.167902
XCG 2.106992
XDR 0.815758
XOF 655.923361
XPF 119.331742
YER 281.446998
ZAR 20.617273
ZMK 10551.119794
ZMW 27.912569
ZWL 377.444665
  • RBGPF

    3.9500

    75.43

    +5.24%

  • NGG

    1.1800

    70.1

    +1.68%

  • CMSD

    0.5000

    24.46

    +2.04%

  • SCS

    0.0900

    17.14

    +0.53%

  • RELX

    0.2500

    47.05

    +0.53%

  • BTI

    0.5900

    56.02

    +1.05%

  • GSK

    0.8900

    40.5

    +2.2%

  • RIO

    1.5100

    63.97

    +2.36%

  • RYCEF

    0.0200

    14.61

    +0.14%

  • BCC

    2.7900

    90.02

    +3.1%

  • BP

    -0.3700

    33.93

    -1.09%

  • CMSC

    0.2900

    24.23

    +1.2%

  • VOD

    0.0600

    11.81

    +0.51%

  • BCE

    0.2500

    24.72

    +1.01%

  • JRI

    0.0500

    13.62

    +0.37%

  • AZN

    -0.0800

    81.7

    -0.1%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

T.Kolar--TPP